Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Piper Jaffray today maintained an Overweight rating on MannKind

Takeda may be another potential partner. They have recently lost market exclusivity for Actos and revenues fell down quite a bit. They have experience in diabetes sales & marketing.

Oncostat

Share
New Message
Please login to post a reply